Relationship between Age and the Ability to Break Scored Tablets by Kim Notenboom, Kim Notenboom, Herman Vromans, Herman Vromans, Maarten Schipper, Hubert G.M. Leufkens, Hubert G.M. Leufkens, Marcel Louis Bouvy, Marcel Louis Bouvy

Connect to this object online.

Getting the Right Evidence After Drug Approval by Rick A. Vreman, Rick A. Vreman, Hubert G. M. Leufkens, Aaron S. Kesselheim

Connect to this object online.

Price changes of antibiotics and perceived substitutes in the context of OTC policy changes in Mexico and Brazil by Yared Santa-, Veronika J Wirtz, Hubert G M Leufkens, Aukje K Mantel-Teeuwisse

Connect to this object online.

Longitudinal study of Good Pharmacy Practice roles covered at the annual world pharmacy congresses 2003-2019 by Zuzana Kusynová, Hendrika A. van den Ham, Hubert G. M. Leufkens, Aukje K. Mantel-Teeuwisse

Connect to this object online.

Organizational capacities of national pharmacovigilance centres in Africa: assessment of resource elements associated with successful and unsuccessful pharmacovigilance experiences by H. Hilda Ampadu, Jarno Hoekman, Daniel Arhinful, Marilyn Amoama-Dapaah, Hubert G. M. Leufkens, Alex N. O. Dodoo

Connect to this object online.

Medicine shortages: impact behind numbers by Doerine J. Postma, Kim Notenboom, Peter A. G. M. De Smet, Hubert G. M. Leufkens, Aukje K. Mantel-Teeuwisse

Connect to this object online.

Impact of medicine shortages on patients - a framework and application in the Netherlands by Doerine J. Postma, Peter A. G. M. De Smet, Kim Notenboom, Hubert G. M. Leufkens, Aukje K. Mantel-Teeuwisse

Connect to this object online.

Challenges and Opportunities for Companies to Build HTA/Payer Perspectives Into Drug Development Through the Use of a Dynamic Target Product Profile by Ting Wang, Ting Wang, Neil McAuslane, Wim G. Goettsch, Wim G. Goettsch, Hubert G. M. Leufkens, Marie L. De Bruin

Connect to this object online.

Drug Repurposing for Rare Diseases: A Role for Academia by Sibren van den Berg, Sibren van den Berg, Saco de Visser, Hubert G.M. Leufkens, Carla E.M. Hollak, Carla E.M. Hollak

Connect to this object online.

Identifying Medicine Shortages With the Twitter Social Network: Retrospective Observational Study by Doerine J Postma, Magali L A Heijkoop, Peter A G M De Smet, Kim Notenboom, Hubert G M Leufkens, Aukje K Mantel-Teeuwisse

Connect to this object online.

Switching TNFα inhibitors: Patterns and determinants by Rosanne W. Meijboom, Helga Gardarsdottir, Matthijs L. Becker, Mark C. H. de Groot, Kris L. L. Movig, Johan Kuijvenhoven, Toine C. G. Egberts, Hubert G. M. Leufkens, Thijs J. Giezen

Connect to this object online.

Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies by Lourens T. Bloem, Rick A. Vreman, Niels W. L. Peeters, Jarno Hoekman, Menno E. van derElst, Hubert G. M. Leufkens, Olaf H. Klungel, Wim G. Goettsch, Aukje K. Mantel‐Teeuwisse

Connect to this object online.

Drug Shortages From the Perspectives of Authorities and Pharmacy Practice in the Netherlands: An Observational Study by Doerine J. Postma, Doerine J. Postma, Peter A. G. M. De Smet, Peter A. G. M. De Smet, Christine C. Gispen-de Wied, Hubert G. M. Leufkens, Aukje K. Mantel-Teeuwisse

Connect to this object online.

Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems by Lukas Roth, Daniel Bempong, Joseph B. Babigumira, Shabir Banoo, Emer Cooke, David Jeffreys, Lombe Kasonde, Hubert G. M. Leufkens, John C. W. Lim, Murray Lumpkin, Gugu Mahlangu, Rosanna W. Peeling, Helen Rees, Margareth Ndomondo-Sigonda, Andy Stergachis, Mike Ward, Jude Nwokike

Connect to this object online.